Safety of Percutaneous Ethanol Injection as Neoadjuvant Therapy for Hepatocellular Carcinoma in Waiting List Liver Transplant Candidates-Reference-Cited by-同舟云学术

Safety of Percutaneous Ethanol Injection as Neoadjuvant Therapy for Hepatocellular Carcinoma in Waiting List Liver Transplant Candidates

Published:2005-11 Issue:9 Volume:37 Page:3871-3873
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Castroagudı́n J.F.,Delgado M.,Villanueva A.,Bustamante M.,Martı́nez J.,Otero E.,Tomé S.,Martı́nez S.M.,Segade F.R.,Conde R.,Dominguez-Muñoz E.,Varo E.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference16 articles.

1. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference;Bruix;J Hepatol,2001

2. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma;Llovet;Hepatology,1999

3. Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation;Llovet;Gut,2002

4. Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation;Veltri;Cardiovasc Intervent Radiol,1998

5. Multimodal treatment for hepatocellular carcinoma on cirrhosis;Troisi;Clin Transplant,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway;Journal of Gastrointestinal Oncology;2021-08

2. Propofol suppresses hepatocellular carcinoma by inhibiting NET1 through downregulating ERK/VEGF signaling pathway;Scientific Reports;2020-07-08

3. Liver transplantation for hepatocellular carcinoma: Where do we stand?;World Journal of Gastroenterology;2019-06-07

4. Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same?;Translational Gastroenterology and Hepatology;2017-09-27

5. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma;Clinics in Liver Disease;2017-05